Rashid, MRMRRashidKhairun Nain Nor AripinMohideen, FBSFBSMohideenBaharom, NNBaharomOmar, KKOmarTaujuddin, NMSMNMSMTaujuddinYusof, HHMHHMYusofFaizul Helmi Addnan2024-05-292024-05-292019-02-03Rashid, Mohd Radzniwan & Nor Aripin, Khairun & Syed Mohideen, Fathima & Baharom, Nizam & Omar, Khairani & Taujuddin, Nik & Yusof, Hazira & Addnan, Faizul. (2019). The Effect of Kelulut Honey on Fasting Blood Glucose and Metabolic Parameters in Patients with Impaired Fasting Glucose. Journal of Nutrition and Metabolism. 2019. 1-7. 10.1155/2019/3176018.2090-07322090-072410.1155/2019/31760182-s2.0-85062372756https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062372756&doi=10.1155%2f2019%2f3176018&partnerID=40&md5=bee246c706f00e050b9687f80227686dhttps://www.hindawi.com/journals/jnme/2019/3176018/https://oarep.usim.edu.my/handle/123456789/11412WOS:000459063900001Journal of Nutrition and Metabolism Volume 2019, Article ID 3176018, 7 pagesBackground. Impaired fasting glucose (IFG) poses a higher risk of diabetes. Honey has been reported to improve metabolic abnormalities including lowering hyperglycemia. This study is sought at determining the effect of Malaysian Kelulut honey (KH) on fasting glucose levels and metabolic parameters in IFG patients. Methods. This quasi-experimental intervention study of 30-day duration was conducted among 60 adult patients with IFG. They were allocated into taking 30g/day KH group (experimental group, n=30) and not taking KH group (control group, n=30). Body mass index (BMI), waist circumference, blood pressure (BP), fasting glucose, and lipid profile levels (total cholesterol, triglyceride, high-density lipoprotein, and low-density lipoprotein) were measured before and after treatment. Results. There was no significant difference in all measured variables at day 30 compared to day 1 within both groups. Similarly, all measured variables neither at day 1 nor at day 30 had shown a statistically significant difference between the groups. Conclusions. Daily intake of 30g KH for 30 days resulted in insignificant effect on fasting glucose, fasting lipid profiles, and other metabolic parameters in patients with IFG. Further studies that employ longer study duration are needed to ascertain the finding.enArticle3176018